EASME

EASME is a European Union executive agency that supports small and medium-sized enterprises and promotes innovation in Europe. It manages projects in the areas of small and medium-sized enterprises, as well as the environment, energy, and maritime sectors, funded by COSME, LIFE, and EMFF. EASME organizes the European Sustainable Energy Week and serves industries such as environmental management, energy production, and maritime activities.

Kristalina Georgieva

Vice President

Past deals in Nordic Europe

QDevil

Grant in 2020
QDevil is a manufacturer specializing in electronics and components tailored for quantum electronics research. The company's primary goal is to advance scientific progress in this field by allowing researchers to concentrate on their core work, rather than spending time on auxiliary equipment development. QDevil's flagship product, the QFilter, has been extensively tested and used in leading quantum electronics labs such as Harvard University and the University of Copenhagen over the past five years.

Capitainer

Grant in 2019
Capitainer AB, based in Stockholm, Sweden, specializes in manufacturing innovative blood collection devices for micro sampling, allowing patients to collect their own volume-defined dried blood spots at home. Founded in 2016, Capitainer's technology offers a more accurate and convenient alternative to traditional blood sampling methods, significantly reducing the need for patients to travel for tests. By facilitating remote blood sample collection that can be sent to laboratories through regular mail, Capitainer enhances the efficiency of healthcare providers and contributes to cost and environmental savings associated with managing conventional blood samples.

Brain Stimulation

Grant in 2019
Brain Stimulation AB is a Swedish small and medium-sized enterprise established in 2011, focusing on the assessment and rehabilitation of patients recovering from strokes and traumatic brain injuries. The company utilizes advancements in brain plasticity research to offer innovative rehabilitation solutions, particularly for cognitive impairments and attention disabilities, such as Spatial Neglect. By addressing the global need for effective rehabilitation in conditions like stroke, dementia, traumatic brain injuries, and Parkinson's disease, Brain Stimulation employs a concept known as Enriched Rehabilitation. Their approach combines precision diagnostics with individualized care technology, facilitating effective neurological rehabilitation that can be accessed remotely. This method aims to create a motivating rehabilitation environment that leads to proven and lasting improvements in patients' cognitive and motor functions, ultimately enhancing their recovery process.

Polymer Factory

Grant in 2019
Polymer Factory, established in 2006 at the Royal Institute of Technology in Stockholm, Sweden, is a prominent supplier of advanced dendritic and polymeric materials, also offering contract research services. Its product range includes monodisperse dendritic polymers derived from 2,2-bis(methylol)propionic acid, such as biocompatible bis-MPA dendrimers and dendrons. The company specializes in the synthesis of high-quality macromolecules, custom materials, and calibrants for MALDI-ToF. Polymer Factory holds exclusive rights to produce, market, and sell several advanced materials, and it globally supplies polyester (Boltorn™) and polyester amide (Hybrane®) hyperbranched polymers for research purposes.

Seaweed Solutions

Grant in 2019
Seaweed Solutions AS is a seaweed cultivator and innovator established in 2009, focusing on large-scale ocean farming of seaweed for various applications, including food, feed, pharmaceuticals, and biomaterials. The company has established itself as a leader in European seaweed cultivation, controlling the entire value chain from proprietary seed hatcheries to processing plants. With a patented cultivation technology called Seaweed Carrier, Seaweed Solutions combines extensive knowledge in marine biology and engineering to pioneer modern seaweed farming practices. Its primary operations are based in Norway, where it manages the largest seaweed farms in Europe dedicated to brown macroalgae. The company's objectives include becoming the leading supplier of cultivated biological seaweed and seaweed seeds in Europe. Additionally, Seaweed Solutions forms partnerships and offers turnkey solutions related to cultivation technology, raw material sourcing, market development, and environmental services, thereby supporting sustainable practices in the seaweed industry.

Svarmi

Grant in 2019
Svarmi is an Icelandic company that focuses on unmanned aerial vehicles (UAVs) for applications such as aerial photography and mapping, as well as other specialized tasks. In addition to its UAV offerings, Svarmi has developed a software platform aimed at assisting organizations in building essential digital infrastructure. This software includes a data analytics pipeline that establishes consistent metrics related to biodiversity and aligns with nature-related financial disclosure frameworks. It also facilitates the evaluation of new infrastructure projects, enabling geologists to obtain detailed reporting on their environmental impact.

Minnemera

Grant in 2019
Minnemera is a company based in Stockholm, Sweden, that specializes in developing digital cognitive screening tools. Founded in 2017, the company focuses on creating neurocognitive tests that automatically compare individual results with normative data and personal baseline values to identify abnormalities. This innovative approach aims to enhance the assessment of cognitive function and support healthcare professionals in diagnosing and monitoring cognitive health.

Pre Diagnostics

Grant in 2019
Pre Diagnostics is a Norwegian diagnostic company specializing in the development of innovative in-vitro diagnostic (IVD) products aimed at the early detection of diseases, particularly neurodegenerative conditions like Alzheimer’s disease. The company leverages a proprietary approach based on the premise that specific diseases trigger unique systemic responses in macrophages, which can be measured through blood samples. By focusing on intracellular measurements of disease-specific biomarkers within blood cells, Pre Diagnostics aims to provide healthcare professionals with actionable insights for early diagnosis. Their commitment to creating patient-friendly solutions positions them as a potential leader in the field of early Alzheimer’s detection, utilizing established technologies to develop their biomarker products.

Black Bruin

Grant in 2019
Black Bruin Inc. is one of the world’s leading suppliers of LSHT radial piston-cam lobe hydraulic motors and rotators. Their trade mark Black Bruin offers a high quality solution for agriculture, construction and mining, road building and forestry equipment applications. As an international operator located in Jyväskylä, Central Finland, we employ nearly 100 fully trained professionals and have a distribution network which covers over 25 countries.

ProtectPipe

Grant in 2019
ProtectPipe is a Finnish microbiotechnology company producing an innovative microbe solution that removes organic waste from drainpipes. The microbe solution moves to the areas with build-up in the pipes and devours the waste. That is an ecological way to stop the erosion in pipes and prevent any harmful waste from entering the fragile environment.

Hefring Marine

Grant in 2019
Hefring Marine is an Icelandic startup based in Reykjavík that specializes in advanced marine technology. The company offers the Intelligent Marine Assistance System (IMAS), an AI-driven software solution designed to enhance safety and efficiency for both manned and unmanned vessels. IMAS utilizes artificial intelligence, machine learning, and Internet of Things (IoT) technologies to provide real-time navigation guidance, helping operators minimize risks associated with inexperience and improving situational awareness. The system significantly reduces fuel consumption and carbon emissions, with potential savings of up to 25%, and mitigates wave slamming impacts by as much as 70%. This approach not only protects crew and passengers but also minimizes damage to vessels and equipment, ensuring a safer and more comfortable marine experience.

Trackwell

Grant in 2019
Trackwell Ltd, established in 1996 in Iceland, specializes in developing wireless communication solutions and is recognized for its expertise in mission-critical systems for telecom operators and government agencies. The company offers Mobile Resource Management (MRM) solutions as a software as a service (SaaS), equipping enterprises with tools to effectively manage their resources, including employees, vehicles, vessels, and other mobile assets. Trackwell's comprehensive suite of software includes fleet tracking, field workforce management, and specialized systems for fishing companies, enabling clients to gain real-time visibility into their operations. With hundreds of companies utilizing Trackwell MRM systems to oversee thousands of employees and a significant number of vehicles across various domains, the company has established itself as a leading provider in the resource management sector.

SagaNatura

Grant in 2019
SagaNatura is an Icelandic biotech company that specializes in the development, production, and export of health products derived from premium Icelandic ingredients. The company focuses on the organic herb Archangelica Angelica and high-quality Astaxanthin, offering a range of consumer products that are safe, vegan-friendly, and of Icelandic origin. SagaNatura operates under two primary brands, SagaMedica, established in 2000, and KeyNatura, launched in 2014. The company aims to promote healthier lifestyles through its clean-label nutrition products, which address various health issues, including vision, skin health, energy, and concentration. By leveraging Iceland's pristine environment, SagaNatura is committed to providing high-quality health solutions that contribute to the well-being of consumers.

Microbium

Grant in 2019
Microbium is an R&D company specializing in custom microbiological detection protocols tailored for specific industrial samples. Founded to address the industry's challenges with microbial contamination, Microbium integrates closely with national laboratories and analytical organizations across Russia, Denmark, and Slovenia. The company offers solutions that go beyond conventional microbiological methods, providing rapid analysis suitable for various sectors. Additionally, Microbium has developed electronic devices capable of detecting and eliminating microorganisms in drinking water, wastewater, and products from the chemical and food industries. These devices automate the detection and counting of harmful bacteria, such as E. coli and coliforms, while employing bioremediation processes to effectively remove contaminants. This innovation not only helps users identify and mitigate contaminated areas but also contributes to reducing production costs and lowering the carbon footprint associated with industrial processes.

BioMensio

Grant in 2019
BioMensio Ltd. is a biotechnology company based in Tampere, Finland, established in 2015. It specializes in developing smart multi-analyte handheld detection devices for bio-analytics, providing rapid and on-site detection of various biological targets from a small sample in a single step. The company's offerings include a novel miniaturized micro-array platform that supports the quick development of new bio-screening applications, which are applicable in areas such as saliva testing, food and milk safety, point-of-care diagnostics, and bio-security. BioMensio's technology enables the creation of label-free assays, allowing for the detection of multiple analytes without the need for labeling procedures. Additionally, its Diagnostics-as-a-Service (DXaaS) platform integrates a handheld reader, multianalyte fluid cartridges, and cloud-based analytics, facilitating easier access for original equipment manufacturers (OEM) to develop bio-analysis products and services.

Gedea Biotech

Grant in 2019
Gedea Biotech AB, founded in 2015 and based in Lund, Sweden, focuses on developing an antibiotic-free treatment for vaginal fungal infections, a common issue affecting approximately 75% of women at some point in their lives. The company's key product, GA101, utilizes natural substances to lower vaginal pH, provide physical barrier protection, and inhibit biofilm formation. This innovative approach aims to offer a safe and effective solution for treating and preventing vaginal infections without the use of antibiotics. Gedea Biotech is committed to addressing women's health needs through its unique treatment options.

ChemoTech

Grant in 2019
Scandinavian ChemoTech AB is a clinical development company headquartered in Lund, Sweden. It specializes in cancer care and pain management solutions, primarily through its innovative product, IQWave. This electroporation device uses short electric pulses in conjunction with localized or intravenous chemotherapy to treat various cancers, including head and neck squamous cell carcinoma, malignant melanoma, and breast adenocarcinoma, among others. The company's founders bring extensive experience in surgical oncology and clinical research, driving its commitment to advancing cancer treatment through genuine research and clinical trials. ChemoTech markets its products via distribution channels and a network of opinion leaders across regions such as South East Asia, India, and the Philippines. Established in 2013, the company continues to focus on developing effective therapies for cancer patients.

Attavik

Grant in 2019
Attavik A/S is an innovative technology company originating from Greenland and currently based in Denmark, focused on addressing mobile phone and internet connectivity challenges in rural areas with limited or no coverage. The company's solution leverages a patented technology that facilitates affordable mobile and internet connections through an Adhoc peer-to-peer mesh network. This network allows personal devices to communicate over distances of up to 8 kilometers using Super Wi-Fi technology. Attavik's platform enables users to send text messages, make voice calls, and share data and video, all without relying on centralized servers or traditional telecommunications infrastructure. By providing an effective alternative to conventional service providers, Attavik aims to enhance connectivity for users in underserved regions.

Greenbird Integration Technology

Grant in 2019
Greenbird Integration Technology AS is a software and solutions company based in Oslo, Norway, with additional offices in Stavanger and Palo Alto. Founded in 2009, Greenbird specializes in IT advisory services and integration solutions for both public and private organizations across Europe. The company offers a platform known as Utilihive, designed as a domain-specific integration platform as a service (iPaaS) tailored for utilities, facilitating the digital transformation of smart grids, smart cities, and the industrial Internet of Things. Utilihive supports over 65 million clients in regions including Scandinavia, Germany, the UK, the Middle East, and the Far East. Greenbird also provides consulting services in strategic advisory, enterprise architecture, and solution design. In August 2023, Greenbird was acquired by GE Vernova, leading to the rebranding of its technology platform, now known as GridOS Connect, which serves as the foundation for the GridOS Data Fabric.

QDevil

Grant in 2019
QDevil is a manufacturer specializing in electronics and components tailored for quantum electronics research. The company's primary goal is to advance scientific progress in this field by allowing researchers to concentrate on their core work, rather than spending time on auxiliary equipment development. QDevil's flagship product, the QFilter, has been extensively tested and used in leading quantum electronics labs such as Harvard University and the University of Copenhagen over the past five years.

EmeraMed

Grant in 2019
EmeraMed Limited is a privately held biotechnology company based in the Republic of Ireland, with operations in Ireland, Sweden, and the United States. The company's ownership group consists mainly of physicians, dentists, and patients who have previously used its products as dietary supplements. EmeraMed is focused on developing a lipophilic antioxidant capable of penetrating the blood-brain barrier. The company's primary goal is to chelate free iron and various heavy metals, including mercury and lead, which can generate harmful free radicals. By addressing these issues, EmeraMed aims to help healthcare providers restore normal mitochondrial function and enhance overall health.

Nornir

Grant in 2019
Nornir is a smart city operator based in Oslo, Norway, specializing in the development of a web-based semantic networking platform that connects physical objects to the internet. The company offers a bijective network, which integrates artificial intelligence services and enhances the Internet of Things (IoT) with collective intelligence. Nornir's platform provides end-to-end software infrastructure and wireless coverage specifically tailored for smart cities, allowing for the monitoring and maintenance of IoT infrastructure. Through its innovative approach, Nornir empowers communities to innovate and create new markets, positioning itself as a leader in network automation and AI-driven services in diverse environments.

Joma International AS

Grant in 2019
Joma International AS is a nanotechnology company located in Bergen, Norway. They specialise in titania nanoparticles and photocatalysis. Joma was founded in 2005 with a plan to mine and utilize various metals from the mountain Joma in mid-Norway. The focus later turned towards titania and how to make nanoparticles from this material. During a thorough development phase they created a unique nanoparticle with a patented and scalable production process. Joma is an R&D driven company and they are actively exploring new areas of use for their particle. In 2014, they built up an in-house lab for analysis and development, which allows us to formulate products with their tiny particles as the key component. The development work is driven by close collaborations with their customers, to find the best suited products for their needs. They have high standards when it comes to quality and performance, and are committed to their customers. They make surface treatment products for many different surfaces, because they do not believe that one single product can serve all applications. Their products which are tailor-made for concrete are now ready to hit the market – to make the world a cleaner place.

Goava

Grant in 2019
Goava, founded in late 2016 by Jonas Ehne, Henrik Stridsberg, Carl Hall, and Johan Rogebrant, operates a sales intelligence platform that helps businesses identify and target qualified leads. Utilizing big data and machine learning, Goava's platform provides sales teams with accurate and actionable insights through a user-friendly digital interface. This enables companies to efficiently track leads and customers, streamlining their sales processes. Additionally, Goava has received a publishing certificate from the Swedish Press and Broadcasting Authority, further establishing its presence in the market.

BoMill

Grant in 2019
BoMill AB specializes in grain quality sorting solutions, focusing on the analysis and separation of granular products such as wheat, durum wheat, barley, and oats. The company offers two main products: TriQ, a large-scale grain quality sorting solution, and IQ, designed for laboratory use. Founded in 2001 by Swedish biochemist Bo Löfqvist, BoMill has extensive expertise in single kernel sorting technology. The company provides additional support services, including customer care and installation, and serves various sectors such as seed cleaning, malt houses, and flour mills. Headquartered in Malmö, Sweden, BoMill markets its technology and know-how across Europe, North America, and Australia, utilizing its own sales organization as well as agents and distributors.

Breivoll Inspection Technologies

Grant in 2019
Breivoll Inspection Technologies (BIT) is a prominent provider of water pipe inspection services based in Tromso, Norway. The company specializes in the condition assessment, maintenance, and upgrading of metallic water pipes and critical water infrastructure. BIT enables utilities in the water industry to evaluate the status of their infrastructure, promoting a proactive approach to pipeline management. Utilizing advanced Acoustic Resonance Technology (ART), BIT conducts in-line inspections of metallic water and district heating pipes. This innovative technology allows for precise measurements of both internal and external corrosion, pipeline thickness, and leak detection. The PipeScanner, a lightweight device weighing only 30 kilograms, is equipped with two cameras to identify obstacles and foreign objects within the pipes, ensuring comprehensive assessments for better infrastructure management.

OnDosis

Grant in 2019
OnDosis is a company focused on transforming medication delivery through its proprietary technology, which allows for flexible and individualized dosing of oral medicines formulated as micro units. The company aims to enhance disease management, support patient adherence, and improve convenience for individuals with conditions such as ADHD, pain management, and organ transplant immunosuppression. By offering improved dosing options, OnDosis seeks to address significant healthcare burdens and ultimately enhance patient outcomes. Founded in 2017 and headquartered in Gothenburg, Sweden, OnDosis emerged from research initiated at AstraZeneca and is supported by strategic partnerships in formulation, device development, regulatory affairs, and business development. The company's innovative dosage manager integrates digital technologies with conventional drug treatments, positioning it to make a meaningful impact in personalized medicine.

Samplix

Grant in 2019
Samplix is a biotechnology company based in Herlev, Denmark, focused on single-molecule sample preparation for DNA and RNA. It has developed the Xdrop™ technology, which utilizes a unique “water-oil-water” droplet system to create millions of reaction chambers for handling individual DNA molecules. This innovative approach allows for targeted enrichment of large DNA fragments and enables researchers to sequence specific genetic regions effectively. Samplix's technology addresses the limitations of existing multi-molecule preparation methods, providing enhanced precision and sensitivity while simplifying the sample preparation process. Its solutions empower scientists to make informed research decisions, particularly in applications related to virus integration and CRISPR editing.

Pila Pharma

Grant in 2019
Pila Pharma AB is a clinical stage biotech company based in Malmö, Sweden, focused on developing XEN-D0501, a potent and selective TRPV1 antagonist. This innovative compound is being investigated as a treatment for type 2 diabetes, obesity, and the rare painful condition known as erythromelalgia. XEN-D0501 has undergone testing in over 300 subjects during phase 1 and phase 2 trials, demonstrating a favorable safety profile in healthy volunteers and patients with various conditions, including overactive bladder disease and chronic cough. The compound has shown efficacy in improving glucose-stimulated insulin secretion in type 2 diabetics. Recent preclinical studies have completed successfully without any registered side effects, allowing XEN-D0501 to advance to longer clinical trials. In July 2022, Pila Pharma received US Orphan Drug Designation for this compound in the context of erythromelalgia.

EpiGuard

Grant in 2019
EpiGuard is a Norwegian company founded in 2015 by a group of doctors from Oslo University Hospital, alongside co-founders Inven2, Eker Group, and Hansen Protection. The company specializes in the development and manufacture of medical transportation systems designed to safely transfer patients with contagious diseases. EpiGuard's flagship product is a single-patient isolation and transport system that helps prevent the spread of infections to the environment and protects patients from contaminated surroundings. This innovation not only safeguards medical staff but also ensures that patients receive proper care during transport. With expertise spanning various medical fields, including intensive care and infectious diseases, EpiGuard aims to enhance safety and efficiency in patient transport.

Vulcur Medtech

Grant in 2019
Vulcur Medtech is a medical device development company based in Vanløse, Denmark, established in 2018. The company specializes in wound healing through its innovative VMT laser technology, which targets chronic wounds that are otherwise difficult to treat. This advanced device utilizes laser pulses that effectively eliminate biofilm-producing bacteria while preserving healthy human cells, promoting the body's natural healing process. By significantly reducing healing time, Vulcur Medtech enhances the quality of life for patients suffering from chronic wounds.

PlatoScience Medical

Grant in 2019
PlatoScience ApS, founded in 2015 and located in Copenhagen, Denmark, specializes in neurostimulation technology through its product, the PlatoWork headset. This device employs transcranial direct current stimulation (tDCS), a non-invasive method that modulates neuronal activity by applying low-intensity currents to the scalp via electrodes. The technology aims to enhance synaptic plasticity and facilitate a targeted mindset, enabling users to achieve deep focus for various tasks. By making neurostimulation accessible and user-friendly, PlatoScience seeks to support mental health and improve cognitive performance, catering to individuals seeking to optimize their mental capabilities.

Mussila

Grant in 2019
Mussila is an Icelandic EdTech company focused on providing innovative digital learning solutions for children, specifically in music education. The company employs a unique Learn, Play, Create methodology that combines gaming with classical music courses to engage children in learning music through enjoyable exercises. Mussila's award-winning apps are designed to keep children motivated while they learn to play musical instruments, fostering creativity and a love for music in a fun and interactive way.

Raytelligence

Grant in 2019
Raytelligence AB, a subsidiary of Swedish Adrenaline founded in 2015, specializes in developing microwave sensors for the healthcare and industrial markets. The company focuses on vital sign monitoring, offering products such as the RayVS1 sensor, which is capable of monitoring heartbeat, movement, and body position. Raytelligence's innovative solutions include cloud-based signal processing and analysis services, facilitating home monitoring for users. The company has received recognition for its advancements, including a grant from the Swedish Innovation Bureau to support the development of its radar sensor technology. Since its inception, Raytelligence has successfully certified its sensor for home use and established partnerships for sensor development in various applications, including the road construction industry and e-Health initiatives. The team at Raytelligence combines expertise in industrial design and radar signal processing, positioning the company as a key player in the sensor technology sector.

Elliptic Labs

Grant in 2019
Elliptic Laboratories A/S, headquartered in Oslo, Norway, specializes in software-based artificial intelligence (AI) virtual smart sensors for various industries, including smartphones, IoT, laptops, and automotive. Established in 2006, the company offers a range of AI virtual sensors that include security, proximity, gesture, and presence detection. Its Virtual Smart Sensor Platform™ utilizes existing device sensors, enabling manufacturers to create more intuitive and efficient devices while reducing the need for dedicated hardware. This platform provides capabilities such as 360-degree presence sensing and touch-free gestures through advanced ultrasound and machine learning algorithms. Elliptic Labs operates in multiple countries, including the United States, China, South Korea, and Japan, positioning itself as a leader in AI sensor technology.

Scandion Oncology

Grant in 2019
Scandion Oncology A/S is a biotechnology company based in Copenhagen, Denmark, focused on developing treatments for chemotherapy resistance in cancer patients. Founded in 2017, the company is advancing its lead product, SCO-101, which is currently undergoing Phase II clinical trials for breast and colorectal cancers. Additionally, it is working on SCO-201, a product in late pre-clinical development aimed at treating solid tumors. Scandion Oncology collaborates with the University of Copenhagen to co-develop SCO-301, a candidate designed to reverse drug resistance, and has partnered with Per Norlén to investigate the combined anti-tumor effects of mitazalimab and SCO-101 in resistant tumor models. The company's mission is to enhance treatment outcomes and quality of life for cancer patients who experience chemotherapy resistance, addressing a significant challenge in oncology where nearly half of patients do not respond to chemotherapy.

ImmuneBiotech

Grant in 2019
ImmuneBiotech AB, founded in 2013 and based in Lund, Sweden, specializes in the research and development of innovative microbiome therapeutics. The company focuses on creating novel probiotics derived from lactic acid bacteria and synbiotic formulations that aim to influence gut microbiota and immune system responses. ImmuneBiotech's therapeutic products include combinations of probiotics, prebiotics, and proteins, specifically designed to address various inflammatory disorders such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. By leveraging its online platform, the company seeks to enable healthcare professionals to prevent and treat autoimmune and other chronic inflammatory conditions effectively.

Modvion

Grant in 2019
Modvion AB, founded in 2015 and based in Gothenburg, Sweden, specializes in the design and development of modular wind power towers constructed from renewable composite materials. The company's innovative modular technology simplifies construction logistics by facilitating transportation and installation of towers over 120 meters tall. This approach not only reduces costs associated with traditional steel tower construction but also enhances efficiency in harnessing wind energy. By leveraging engineered wood products, Modvion aims to improve the economic viability of wind power investments for power plant construction businesses, ultimately contributing to a more sustainable energy landscape.

Elypta

Grant in 2019
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.

Ekowasher

Grant in 2018
Ekowasher is a manufacturer and developer based in Stockholm, Sweden, specializing in eco-friendly washing systems. The company designs and produces closed, water-efficient cleaning solutions that minimize environmental impact. Its inaugural product, Hullwasher, was introduced in 2015 for cleaning the bottoms of boats. In 2018, Ekowasher expanded its product line with the launch of Graffiti blades, which are designed for effective graffiti removal on various surfaces. The company focuses on providing environmentally optimized washing systems that significantly reduce water consumption.

RoboFit ApS

Grant in 2018
RoboFit ApS is a Danish company located in Christiansfeld that specializes in the manufacture and marketing of a rehabilitation robot designed to assist individuals with very weak muscles in exercising their shoulder region. This innovative technology enables patients to train effectively by utilizing the full range of motion of the shoulder, making the rehabilitation process both measurable and motivational.

Comptek Solutions

Grant in 2018
Comptek Solutions Oy, founded in 2017 and based in Turku, Finland, specializes in developing advanced surface engineering technology known as Kontrox. This quantum-level process is designed to create defect-free surfaces for compound semiconductor devices, addressing the critical issues of oxidation that lead to performance limitations in products like MicroLEDs, lasers, and power electronics. By improving the crystalline quality of III-V-based semiconductors, Kontrox technology significantly enhances device performance, achieving notable improvements such as a 250% increase in efficiency and a 90-fold reduction in power consumption. Comptek Solutions has applications across various sectors, including optoelectronics and radio frequency technologies. The company has gained recognition for its innovative approach, receiving a Horizon2020 SME phase I grant from the EU in 2018 and being shortlisted as a top semiconductor spinoff in the inaugural Spinoff Prize competition by Nature Research in 2020.

Gleechi

Grant in 2018
Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

Moonwalk Innovation

Grant in 2018
Moonwalk turns Epic Challenges into Stellar Startups to improve 1 Billion Lives from its venture studios in London and Oslo. Moonwalk revolutionized venture creation with its award-winning system of innovation, entrepreneurship and investing. It made 3 portfolios of 18 startups now growing on 3 continents in 3 years. It engaged 150 innovators backed by 300 angel investors. Moonwalk made 5 companies for a Norwegian post-oil economy; democratizes health with 8 startups in seed stage; and reinvents education with 5 startups in seed stage.

Meo

Grant in 2018
Meo, founded in 2015 and based in Copenhagen, Denmark, operates a user identity platform designed to enhance trust in the internet economy. The platform enables compliance teams in regulated sectors to verify customer identities securely, thereby mitigating financial, reputational, and legal risks. It simplifies the management of customer data, allowing businesses to obtain, handle, and store information from both individuals and organizations while ensuring compliance with privacy regulations. By facilitating secure data sharing and implementing measures to prevent money laundering, Meo empowers users to maintain control over their personal data and identity online.

IRLAB Therapeutics

Grant in 2018
IRLAB Therapeutics AB is a Swedish research and development company focused on creating innovative treatments for neurological disorders, particularly Parkinson’s disease. The company is advancing several drug candidates, including Mesdopetam, a dopamine D3 receptor antagonist, and IRL752, which targets postural dysfunction. Both compounds have successfully completed Phase IIa clinical trials. Additionally, IRLAB is exploring other research programs aimed at addressing neurodegenerative disorders and aging, such as IRL942, P001, and P003, which seeks alternatives to levodopa for Parkinson’s treatment. By focusing on the core dysfunctions associated with Parkinson’s disease and dementias, IRLAB aims to enhance the quality of life for patients suffering from these conditions. The company is headquartered in Gothenburg, Sweden.

Klaria Pharma Holding

Grant in 2018
Klaria Pharma Holding AB is a Swedish pharmaceutical company that specializes in the development and commercialization of innovative rapid-acting products for managing migraine and cancer-related pain. Utilizing a patented drug delivery platform, the company employs an alginate-based polymer film that adheres to the oral mucosa, enhancing the efficacy of well-established pharmaceuticals. Klaria's approach combines advanced technology with proven medications, offering significant benefits and potential applications for patients. The majority of the company's operations are based in Sweden, where it focuses on improving treatment options for pain management.

720 Degrees

Grant in 2018
720 Degrees Oy specializes in developing a cloud-based analytics solution for monitoring indoor environmental quality. Founded in 2012 and based in Helsinki, Finland, with an additional location in New York, the company offers a range of sensors and software that collect and analyze real-time data on air quality, thermal comfort, and noise pollution. Their air quality sensors measure various parameters, including temperature, relative humidity, carbon dioxide, total volatile organic compounds, and particulate matter. The platform aims to enhance workplace health and satisfaction, allowing organizations and building owners to create optimal working environments. By leveraging artificial intelligence and data-driven insights, 720 Degrees enables businesses to improve office conditions, promote occupational health, and enhance overall job satisfaction and performance.

AcouSort

Grant in 2018
AcouSort is a Swedish company specializing in the development and sale of laboratory products and integrated solutions that utilize ultrasound technology for the separation, washing, and enrichment of biological samples. Its offerings cater to researchers and life science companies, focusing on the automated preparation of samples such as blood cells, bacteria, and extracellular vesicles. The technology is rooted in acoustofluidics research from the esteemed group led by Professor Thomas Laurell at Lund University's Department of Biomedical Engineering. Key products include AcouTrap, AcouWash, and AcouPlasma, which facilitate efficient handling of microscopic particles in microfluidic channels for research and diagnostic applications.

Stayble Therapeutics

Grant in 2018
Stayble Therapeutics AB is a clinical-stage pharmaceutical company based in Gothenburg, Sweden, focused on developing an innovative injection treatment for chronic low back pain caused by degenerative disc changes. The company's primary product, STA363, is an intradiscally injected formulation designed for patients who do not experience relief from conventional treatments such as analgesics and physiotherapy. This minimally invasive treatment aims to address the underlying causes of discogenic pain by stabilizing the disc and preventing the leakage of inflammatory mediators. STA363 is administered as a single injection, with the potential for long-lasting effects and minimal rehabilitation requirements. The experienced multidisciplinary team behind Stayble Therapeutics includes renowned researchers and seasoned professionals from the pharmaceutical industry, all dedicated to alleviating the suffering of millions impacted by chronic back pain.

Think Outside

Grant in 2018
Think Outside AS is a technology startup based in Bergen, Norway, specializing in the development of advanced real-time radar equipment for avalanche sensing and outdoor applications. Founded in 2017, the company focuses on producing innovative products that enhance safety in skiing and hydropower sectors. Its flagship product, Sknow, provides skiers with real-time data on snow layers directly beneath their skis, including information on snow depth, layering, density, and snow water equivalent (SWE). By integrating software solutions with its hardware, Think Outside aims to reduce health and safety risks associated with skiing in avalanche-prone areas, enabling users to make informed decisions regarding slope conditions and potential hazards.

Cellink

Grant in 2018
Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.

Combain

Grant in 2018
Combain is a prominent geolocation service provider specializing in accurate positioning for connected IoT devices. With one of the largest databases of cell IDs and WiFi information globally, it offers extensive resources for both indoor and outdoor device geopositioning, encompassing over 88 million cell IDs and 1.3 billion WiFi access points from more than 200 countries. The company caters to a diverse clientele, including leading mobile network operators, cybersecurity firms, and IoT device manufacturers. Combain provides its positioning services through a cloud-based API known as Combain CPS API, as well as via its IoT platform, IoTmate.io. Headquartered in Lund, Sweden, with an additional office in Palo Alto, USA, Combain serves customers around the world, enhancing the accuracy and efficiency of mobile device localization.

Xnovo Technology

Grant in 2018
Xnovo Technology ApS is the commercial result of more than 15 years of Synchrotron and Diffraction-Imaging research at the Technical University of Denmark (DTU). Driven by an urge to make 3D crystallographic X-ray technology accessible for a wider range of materials scientists, Xnovo Technology ApS was founded in December 2012 by Senior Scientist Erik Mejdal Lauridsen, DTU-Energy Conversion, and Professor Henning Friis Poulsen, DTU-Physics.

Airofit

Grant in 2018
Airofit is a Danish company that offers a specialized training system designed to strengthen the lungs and improve breathing. Originally developed for medical applications to assist patients with respiratory issues such as asthma and bronchitis, Airofit's equipment focuses on training the diaphragm and intercostal muscles. The system gradually increases the workload on the respiratory system, leading to enhanced breathing power and efficiency. While initially aimed at medical patients, Airofit has proven effective for a broader audience, including athletes seeking to boost endurance and respiratory strength, as well as singers and musicians who benefit from improved coordination and sound quality. The company's innovative approach not only enhances respiratory capacity but also helps reduce the reliance on medications for individuals with chronic respiratory conditions.

Tracegrow

Grant in 2018
Tracegrow is a Finnish cleantech company focused on the circular economy, specializing in the extraction and purification of vital trace elements, specifically Zinc and Manganese, from alkaline batteries. This innovative technology enables the safe reuse of these micronutrients, creating ecological fertilizers for agricultural applications. By transforming waste materials into valuable resources, Tracegrow addresses two critical global issues: the environmental concerns associated with battery disposal and the micronutrient deficiencies in farmland. The company's approach promotes sustainable practices by minimizing the exploitation of the planet's limited resources, positioning Tracegrow as a leader in the development of environmentally friendly solutions for farming and industry.

Airmee

Grant in 2018
Airmee is a logistics company based in Stockholm, Sweden, specializing in last-mile distribution solutions for e-commerce businesses. Founded in 2016, Airmee offers same-day and express delivery services, utilizing a technology-driven platform that incorporates machine learning and proprietary optimization techniques. This platform allows e-commerce companies to schedule and manage their delivery routes in real time, ensuring efficient and timely service. By focusing on environmentally sustainable practices, Airmee aims to enhance the delivery experience while minimizing the environmental impact of logistics operations. As one of Europe's rapidly growing logistics startups, Airmee is positioned to streamline supply chain processes and improve overall delivery efficiency for its clients.

Cognibotics

Grant in 2018
Cognibotics AB, based in Lund, Sweden, specializes in methods and services aimed at improving the performance and longevity of robotic systems. The company focuses on determining critical robot properties such as backlash, friction, and non-linear compliance, which are essential for effective operation in various applications. Cognibotics offers innovative solutions for joint property assessment that enable robots to function in areas where traditional calibration methods fall short. Additionally, the company provides techniques for monitoring mechanical wear and maintenance needs, enhancing the reliability and cost-effectiveness of robotic systems. By improving accuracy and predictability in robotic joint and link designs, Cognibotics supports the development of both new robots and the programming of cooperative robots, thereby expanding their application potential and lifespan.

Colzyx

Grant in 2018
Colzyx AB is a biotechnology company based in Lund, Sweden, specializing in innovative wound care solutions. Established in 2012, the company focuses on developing bioactive wound dressings that leverage groundbreaking research from the Medical Faculty at Lund University. Colzyx's products utilize the alpha-3 chain from human collagen VI, which has shown remarkable wound healing and antimicrobial properties. By harnessing powerful biological regeneration mechanisms, these dressings not only accelerate the healing process for both active and chronic wounds but also provide protection against a wide range of bacteria, including multidrug-resistant strains. This approach aims to enhance patient outcomes by promoting rapid wound closure and minimizing the risk of bacterial infections.

Asco Harvester

Grant in 2018
Asco Harvester produces a marine mower that mows marine vegetation by the seacoast along with cleaning waste and garbage which increasingly piles up in vulnerable places. Asco is easy to manage and has alot of safety equipment on board. Asco is solid, highly technical and has been modified by innovative developments in recent years. Asco is suitable both for water catchments and in difficult weather conditions at sea thus the Asco reaches different target groups. Asco is designed and constructed from scratch in Iceland. All types of Asco have similar characteristics, therefore most equipment can be used in various Asco types.

CytaCoat

Grant in 2018
CytaCoat is a private Swedish company headquartered in the Karolinska Institutet Science Park in Solna, established by researchers from the Karolinska Institute and the Royal Institute of Technology. The company focuses on developing an innovative antibacterial coating technology for medical devices aimed at preventing healthcare-associated infections. Their proprietary polymer surface demonstrates effectiveness against several problematic pathogenic bacteria, addressing a significant challenge in healthcare. CytaCoat’s technology is designed to be stable under varying pH and ionic conditions, minimizing the release of potentially toxic components and preventing bacterial colonization without relying on antibiotics, which can lead to resistance. The company operates a fully equipped laboratory for microbiology evaluations and technology optimization, and it has established collaborations with clinical partners at the Karolinska University Hospital. Additionally, CytaCoat works with consultants specializing in regulatory affairs, clinical research, patenting, and specialized analyses to advance their product towards commercial viability and licensing opportunities.

Fjolblendir

Grant in 2018
Fjölblendir ehf is a research and development company based in Kópavogur, Iceland, with facilities in Ireland. The company specializes in the invention and development of fuel systems and carburetors utilizing its novel Total Combustion Technology (TCT). This innovative TCT-based fuel system is specifically designed for small off-road engines (SORE), enabling them to comply with EPA phase III regulations without requiring engine modifications or the use of catalysts. Fjölblendir aims to create fuel systems that are not only straightforward to manufacture and calibrate but also generate lower emissions compared to conventional systems.

Comparo.dk

Grant in 2018
Comparo.dk is an online platform based in Copenhagen, Denmark, that assists users in finding the most affordable car and travel insurance packages. Launched in June 2013, the service simplifies the insurance management process by aggregating data from various family insurance policies. It provides users with a clear overview of their coverage, payment history, and comparisons of different insurance plans. By offering a range of options from multiple insurance providers, Comparo.dk enables users to make informed decisions, choose the best coverage for their needs, and efficiently manage their insurance policies through a single application.

Xzero

Grant in 2018
Xzero is a Swedish company that has spent 20 years in R&D for a new technology for process water in the micro- and nanoelectronics industries. The basic idea is to recycle the water from waste water into Ultrapure Water. The most recent challenge has been to remove nanoparticles in order to make sure these are not spread in the environment and not enter the Ultrapure Water used in cleaning of the nanoelectronics. Third party tests done by The Royal Institute of Technology and Swedish Environmental Research Institute (Sweden), Clarkson University (US), Manta Inc(US) and Anton Paar (Austria) have confirmed that Xzero technology is more efficient than existing technologies in removing nanoparticles from water. In January 2015, Xzero started to industrialize the technology in co-operation with researchers at the Royal Institute of technology in Stockholm, Sweden and at the leading European organization for microelectronics development – imec in Leuven, Belgium. Testing of the first full scale prototype of the industrialized equipment commenced in August 2016 and final industrialized equipment is slotted to be delivered to imec during the first half of 2019. In order to complement the researchers already working on the project, Xzero is recruiting experienced and professional engineers for the industrialization work and experienced sales people for tha marketing. In the commercialization phaseXzero will continue working with imec. Imec has offices in Belgium, the Netherlands, Taiwan, USA, China, India and Japan and a staff of about 2,400 people including several hundred of industrial residents from leading international nanoelectronics companies. Through imec we will be able to reach the largest part of Xzero’s future customers.

TILT Biotherapeutics

Grant in 2018
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses aimed at enhancing cancer treatments. The company's patented technology focuses on using these viruses to improve tumor T-cell therapies, including tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibitors. TILT Biotherapeutics is recognized as a leader in the global market for integrating oncolytic viruses with cancer immunotherapy. Their product pipeline includes TILT-123, TILT-234, and TILT-321, which are designed to modify the tumor microenvironment and counteract its suppression of immune responses. The innovative approach has the potential to replicate the successes seen in CAR-T therapy for solid tumors, similar to those achieved in hematological cancers.

Olfactomics

Grant in 2018
Olfactomics is a Finnish university-based spinoff company focused on advancing surgical tissue assessment technology, particularly in breast-conserving lumpectomies. The company has developed innovative energy-based surgical instruments that analyze surgical smoke, which contains critical information about the operated tissue. This real-time analysis enhances the surgeon's situational awareness during procedures, allowing for the detection of cancerous tissue at margins that might otherwise be overlooked. By improving the accuracy of tumor removal in a single operation, Olfactomics aims to minimize the resection of healthy tissues and reduce the likelihood of costly re-operations.

ColdZymes

Grant in 2018
Coldzymes develops enzymes from microorganisms isolated from cold environments from all over the World, e.g. from Greenland, Alaska, Svalbard, Antarctica. Cold-active enzymes from Coldzymes may be used in novel industrial processes that are more - Economic, due to lower consumption of fossil fuel - Efficient, due to increased specific activity of cold-active enzymes - Hygieinic, because food spoilers do not grow at low temperatures Coldzymes’ enzymes are developed in accordance with the Convention on Biological Diversity. Coldzymes is a project under the multi-disciplinary and multi-national initiative Greenland Perspective that brings together researchers, civil society, industry and authorities to explore how Greenland’s human and natural resources can be used to develop new technologies, business opportunities and societal models.

Peerpilot

Grant in 2018
PeerPilot ApS is a Copenhagen-based company that operates a performance-based talent assessment platform designed to streamline the recruitment process. Founded in 2013, the platform facilitates mass candidate screenings and individual recruitments by allowing candidates to collaborate on job-specific business cases in a virtual environment. It evaluates and scores candidates based on their activity, impact, and collaboration during these tasks. By automating the screening and assessment process, PeerPilot enables employers to analyze real-time social work data to identify the most suitable candidates for their roles, thereby enhancing the overall hiring experience.

Aqua-Q

Grant in 2018
Aqua-Q is a Swedish cleantech company with over 20 years of experience in water management and treatment. The company specializes in developing innovative products and processes aimed at ensuring safe and clean water for drinking, treated wastewater, and reuse. Aqua-Q's systems enable water utility operators to detect waterborne outbreaks in a timely manner, allowing for immediate intervention to minimize potential consequences. The company offers modular ozone disinfection systems and holds patents for technologies that effectively eliminate Legionella bacteria in water systems, as well as cold water disinfection methods that verify and disinfect the cleanliness of tanks and pipes. Their solutions are applicable across various industries, including dairy, breweries, and bottled water manufacturing, and provide critical early warning monitoring and automatic biological sampling for pathogen detection, ensuring proactive management of water quality.

Glucostratus

Grant in 2018
Glucostratus Ltd develops innovative solutions for remote monitoring of blood glucose levels, primarily targeting patients with diabetes and healthcare professionals. Founded in 2005 and based in Helsinki, Finland, the company provides a cloud-based platform that captures blood glucose data via mobile technology, enabling patients to share their results with healthcare providers. This system allows professionals to set personalized targets and receive automated alerts regarding any deviations, facilitating effective remote monitoring of insulin treatment. Additionally, Glucostratus offers a digital solution for diagnostic testing and generates comprehensive reports in accordance with treatment guidelines. Their services include a user-friendly IoT solution designed for elderly diabetics, ensuring accessibility for those with limited technological skills and addressing the growing needs of the home care sector.

Seafood IQ

Grant in 2018
Seafood IQ is an Icelandic, award-winning Seafood-tech venture that was founded in 2015. They are seafood veterans and P.h.D level technologists that believe, by turning the complex into simple with smart technologies they can create the tools needed to increase trust, comfort, and profit within the seafood value chain. Their team is developing the worlds’ only data platform that combines IoT/RFID, Blockchain, and artificial intelligence to create a new level of trust based on unified digital identities, real-time temperature monitoring and cryptographed background information of every box of fish that is manufactured, transported and then sold into the marketplace.

InDex Pharmaceuticals

Grant in 2018
InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

Quiske

Grant in 2018
Quiske is a Finnish technology startup developing a Rowing Performance (RowP) system which helps you become a better rower. The RowP System consists of and app and a pod that together can measure, analyze and provide real time feedback on your rowing, so that you can improve and fine tune your technique, which is especially important when rowing in a crew. Its SW automatically sniffs for rowing strokes and produces real time feedback on both boat specific metrics (boat acceleration and velocity) as well as rower specific metrics (oar and seat work of individual rowers).

Tocircle

Grant in 2018
Tocircle is a mechanical technology company established in 2003, focused on developing rotary vane machines inspired by the concepts of Norwegian inventor Kjell Vading. The company has engaged in extensive development and testing, collaborating with major industry players such as Statoil and academic institutions like the Norwegian University of Life Sciences. Tocircle specializes in energy recovery and production, offering a range of machines including pumps, turbines, multiphase expanders, and compressors. These machines are designed to efficiently handle various gas and liquid mixtures while minimizing noise and vibration, thus reducing the need for additional space-consuming equipment. By addressing the growing global demand for environmentally friendly and resource-efficient solutions, Tocircle aims to establish itself as a prominent player in energy efficiency, electricity production, and oil and gas services in Norway. The company partners with the Norwegian research institute IFE and is associated with OREEC and the German industry association B.KWK.

Gradientech

Grant in 2018
Gradientech AB is a biotech company based in Uppsala, Sweden, specializing in the development and supply of microfluidic products for analyzing cell migration and behavior in response to signaling gradients. The company offers a range of CellDirector products designed for research applications, including the CellDirector Opal and CellDirector Ruby, which facilitate studies on endothelial cell migration, angiogenesis, and tumor cell behavior. Additionally, Gradientech provides complementary tools such as Gradient Marker solutions for visualizing gradient formation, a syringe pump for precise fluid delivery, and a vacuum pump for conducting experiments at elevated temperatures. The company also features the QuickMIC® system for ultra-rapid antibiotic susceptibility testing, which enhances the capabilities of microbiology labs by delivering reliable minimum inhibitory concentration results swiftly. Gradientech serves scientists across academic, pharmaceutical, and diagnostic markets globally, and its products are available for purchase online. The company was incorporated in 2009.

GoSleep

Grant in 2018
GoSleep is a Finnish company that designs and manufactures innovative sleeping pods aimed at enhancing passenger comfort in airports. The GoSleep Pod features a stylish and sleek chair that can easily convert into a flat bed, providing users with a private space to rest amidst the busy airport environment. Each pod offers secure storage for hand luggage beneath the seat, as well as power outlets and USB ports for charging electronic devices. With a moveable shade that blocks out noise and light, the GoSleep Pod allows travelers to recuperate effectively during layovers or delays, making it an ideal solution for those seeking rest in transit.

Memento Payments

Grant in 2018
Memento Ehf is a developer of a cloud-based social payment platform aimed at enhancing the relationship between banks and their customers. Founded in 2014 and based in Reykjavík, Iceland, the company provides a comprehensive software toolkit and mobile payment application that can be seamlessly integrated with existing banking infrastructures. This platform enables banks to launch wallet and peer-to-peer payment services on both iOS and Android devices, facilitating a more engaging and user-friendly banking experience. Memento's vision is to create a Social-to-Bank Relationship Platform, recognizing the importance of technology and regulatory advancements in the financial sector. By focusing on building strong, integrated relationships within consumers' social lives, Memento seeks to empower financial institutions to adapt and thrive in a rapidly evolving fintech landscape.

2cureX

Grant in 2018
2cureX AB operates as a medtech company in Denmark. It is involved in developing IndiTreat, a technology for the treatment of colorectal, ovarian, and kidney cancers. The company was founded in 2006 and is based in Copenhagen, Denmark.

GPX Medical AB

Grant in 2018
Neola Medical AB is focused on advancing neonatal intensive care through its innovative device, NEOLA. This medical technology offers continuous monitoring of lung function and real-time alerts for life-threatening complications in preterm infants. By measuring changes in lung volume and oxygen gas concentration, NEOLA aims to enhance patient care, reduce the duration of intensive care stays, and improve overall health outcomes for vulnerable newborns. The company is rooted in Sweden's rich history of medical technology innovation, which has significantly contributed to advancements in healthcare.

SansOx

Grant in 2017
SansOx Oy, established in 2012 and based in Helsinki, Finland, specializes in innovative solutions for water purification. The company develops and markets advanced technologies aimed at addressing the global clean water market, particularly in the context of increasing water scarcity and the principles of the Circular Economy. SansOx's offerings include systems for aeration and oxidation in various water treatment processes, including drinking water production, fish farming, industrial water processing, and wastewater treatment, all designed to operate with low energy consumption. As a member of the Finnish Cleantech Cluster, SansOx collaborates with credible partners globally to enhance its market presence and is preparing for potential future public listing to support its growth and marketing initiatives.

ErkiTónlist

Grant in 2017
ErkiTónlist was founded in 1985 to promote creative endeavours in music, especially those that for one reason or other did not obtain commercial support. ErkiTónlist sf has issued several LPs and CDs with experimental and theatre music, constructed the MIC database for Icelandic music – www.mic.is, produced music videos for experimental music, organized seminars for young musicians – emphasizing on computer music, initiated and organized the biannual ErkiTid – the first electronic music festival in Iceland, supported the development of CALMUS project , a computer program for musical composition, operated a studio for recording, sound design, video production and programming environment for CALMUS, and released CDs with classical as well as contemporary music.

Rdot Display

Grant in 2017
Rdot Display is a Swedish company focused on transforming the reflective display industry. It specializes in the manufacture of printed displays that are designed to be low power consuming and efficient, catering to small display needs. Rdot's products are environmentally friendly and cost-effective, making them suitable for a variety of applications, including sensors, packaging, disposables, electronic shelf labels, and various consumer electronics. By enabling users to display simple messages with minimal power consumption and cost, Rdot Display aims to provide innovative solutions that meet contemporary demands for sustainability and efficiency.

SAGA Diagnostics

Grant in 2017
SAGA Diagnostics AB is a company specializing in molecular genetic tests and services aimed at enhancing cancer diagnostics and disease monitoring for healthcare providers, biopharmaceutical firms, and academic institutions. Founded in 2016 as a spin-out from a research group at Lund University, SAGA focuses on the analysis of circulating tumor DNA (ctDNA), a critical biomarker for cancer. The company offers a range of services, including gene mutation analysis, chromosome analysis, and non-invasive liquid biopsy testing, which allows for the ultrasensitive detection of actionable mutations. SAGA's proprietary technology supports oncologists and drug developers by enabling the stratification of patient groups and monitoring treatment responses, thereby facilitating more precise cancer medicine and improving patient outcomes. Based in Lund, Sweden, SAGA is driven by a team of experienced scientists and professionals dedicated to advancing cancer research and clinical diagnostics.

GeoSilica

Grant in 2017
geoSilica, founded in 2012 by Fida Abu Libdeh and Burkni Pálsson, originated from their academic research in energy and environmental engineering at the University of Iceland. The company began operations at the Hellisheidi Power Plant, collaborating with ON Energy to exploit the mineral-rich geothermal water. Through a proprietary two-step production process, geoSilica enhances the concentration of silica in the geothermal water without altering its chemical composition, subsequently replacing it with clean groundwater to produce highly pure silica particles. The production process is entirely chemical-free. In late 2014, geoSilica launched its first product, a liquid silica supplement derived from 100% natural ingredients, aimed at promoting health benefits for hair, skin, bones, and muscles. The company is also actively developing new products to expand its offerings.

Radisurf

Grant in 2017
RadiSurf ApS specializes in providing advanced adhesion solutions for a variety of industries, including healthcare, automotive, offshore, nutrition, and electronics. Founded in 2015 and located in Risskov, Denmark, the company develops a range of products designed to facilitate bonding between metal and plastic materials. Its key offerings include the RadiBond adhesion system, a chemical coating for thermoplastics and thermo sets, and RadiPrime Metal-Epoxy Primer Systems that create stable bonds between metals and epoxies. RadiSurf's technology also encompasses nano-coatings that enable adhesion for diverse surfaces, such as metal, glass, and carbon, while addressing challenges in welding and over-moulding processes. The company's innovative solutions support applications in sustainable energy production and storage, enhancing the performance and durability of hybrid materials.

InfiCure Bio

Grant in 2017
InfiCure Bio is a life science company based in Umeå, Sweden, specializing in the preclinical development and validation of drugs aimed at chronic inflammatory and fibrotic conditions. Founded in 2015, it evolved from a project initiated at the Umeå Biotech Incubator by Prof. Dan Holmberg and Dr. Sofia Mayans, leveraging research from their academic work. The company provides a unique preclinical model that simulates the development of fibrosis in various organs, such as the liver and kidneys, which is often preceded by chronic inflammation. This model allows pharmaceutical companies to test their anti-inflammatory and anti-fibrotic drugs comprehensively. InfiCure Bio's services include the setup, execution, analysis, and reporting of results from these effect tests, thereby supporting the development of therapies for significant medical conditions like chronic liver and kidney diseases.

Furhat Robotics

Grant in 2017
Furhat Robotics AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing advanced social robotics platforms. The company designs and manufactures development kits that integrate hardware, software, and APIs, enabling users to create AI interfaces with human-like social intelligence and expressiveness. Furhat's robots can display facial expressions and engage in context-aware interactions, catering to diverse markets such as information services, healthcare, education, and more. With over 70 international business partnerships, the company aims to revolutionize human-machine interactions by mimicking human personality, gestures, and intonation.

Fisheries Technologies

Grant in 2017
Fisheries Technologies is an Icelandic company specializing in the field of fisheries management on a governmental level. The company's main focus is on data collection procedures and related information systems.

Angular Velocity

Grant in 2017
Angular Velocity is a Finnish technology company committed to improving and enriching sports technology with cutting-edge hardware and software solutions.

Ilya Pharma

Grant in 2017
Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in the development of biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients. The company's work is grounded in extensive scientific research conducted at Uppsala University and the Swedish University of Agriculture.

AddiFab

Grant in 2017
AddiFab is a Danish company specializing in additive manufacturing solutions, particularly for rapid prototyping and low-volume production. It offers a proprietary system of 3D printers combined with advanced print resins and processes, allowing manufacturers to create custom injection molds. This innovative approach enables the production of complex parts efficiently and at a lower cost than traditional methods, while also reducing environmental impact. AddiFab's technology allows for the production of unique batches, prototypes, and spare parts without sacrificing material selection, accommodating everything from soft rubbers to hard metals. The company operates from its headquarters in the Greater Copenhagen area, with a branch in Palo Alto, California. Leadership includes CEO Lasse G. Staal, CTO Jon Jessen, and COO Peter L. Sørensen in Denmark, along with CEO Carsten Jarfelt in the U.S.

DACON AS

Grant in 2017
Dacon was established in 1979 and is a leading supplier of safety, rescue, and inspection equipment for professional use. Dacon is a manufacturer, importer, and distributor, with daughter companies offering inspection services in Norway and Thailand, inspection equipment in The Netherlands as well as protective equipment cases/foam converting in Norway.

Spectral Engines

Grant in 2017
Spectral Engines Oy, founded in 2014 and headquartered in Helsinki, Finland, specializes in the development and production of advanced spectral sensors, particularly employing micro-electro-mechanical system (MEMS) technology. The company manufactures miniaturized sensors that make spectroscopy accessible at a competitive price point, catering to various applications including moisture measurements in pharmaceutical powders, food composition analysis, and gas detection. Its product offerings include OEM sensors, application development kits, gas sensors, portable instruments, and software development kits. Spectral Engines serves a diverse range of industries, including agriculture, food and beverage, and pharmaceuticals, providing clients with the capability for cloud connectivity and advanced algorithm integration. As of May 2018, Spectral Engines operates as a subsidiary of m-u-t AG.

Optomed

Grant in 2017
Optomed Oy is a Finnish medical technology company that specializes in retinal imaging devices and solutions. The company focuses on developing, commercializing, and manufacturing handheld fundus cameras that facilitate the screening of various eye diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD). Optomed’s devices are designed to be user-friendly and accessible, making eye disease screenings available in diverse clinical settings worldwide. The company's products meet the international ISO 10940 fundus camera standards and are utilized by private clinics, public hospitals, and non-governmental organizations across major markets such as Europe, the USA, China, and India. In addition to its hardware offerings, Optomed also develops screening software for healthcare organizations. Headquartered in Oulu, Finland, Optomed maintains local offices in Shanghai, China, and Espoo, Finland.

SagaMedica

Grant in 2017
SagaMedica is an Icelandic manufacturer of natural dietary supplements, established in 2000. The company specializes in herbal medicinal products that address common health issues such as sore throat, memory enhancement, and urinary frequency. Drawing on a rich history of herbal remedies used by their ancestors for over a millennium, SagaMedica sources its herbs, particularly angelica archangelica, from Iceland's pristine environment. The company emphasizes eco-friendly harvesting practices and bases its offerings on extensive academic research, ensuring that all products have proven efficacy. By focusing on natural ingredients and a deep connection to Icelandic nature, SagaMedica aims to provide effective solutions for health and vitality.

Offshore Kinetics

Grant in 2017
Offshore Kinetics is a Norwegian small and medium-sized enterprise specializing in the offshore wind sector. The company leverages proven technology and extensive experience from the offshore oil and gas industry to innovate in the offshore wind market. Its primary focus is the development of offshore wind turbine support structures, which are designed to enhance safety during both production and operational phases. By offering a cost-efficient solution, Offshore Kinetics aims to significantly reduce capital and operational expenditures associated with offshore wind farms, thus addressing key technological challenges in the wind energy sector.

Zemission

Grant in 2017
Zemission AB, based in Lund, Sweden, specializes in the development of innovative catalytic combustion technology aimed at achieving efficient and fuel-independent combustion with minimal emissions. With over a decade of expertise, the company has pioneered a multifuel and low-emission combustion concept, enabling flameless combustion suitable for various applications such as automotive heating, renewable energy, and industrial heating. Zemission's unique approach allows for the combustion of liquid fuels, a significant advancement over traditional methods that typically focus on gaseous fuels. The company holds several patents related to its non-monolith technology, positioning it at the forefront of zero-emission heat solutions.

Alelion Energy Systems

Grant in 2017
Alelion Energy Systems AB, based in Nödinge, Sweden, specializes in energy storage solutions and the development of high-performance lithium-ion batteries. Established in 2006 as a spin-out from ETC Batteries and Fuelcells, the company focuses on designing and delivering tailor-made battery systems and power electronics that cater to demanding applications across various industries. Alelion Energy Systems emphasizes the safety and longevity of its lithium-ion cells, which are engineered to offer exceptional cycle performance. The company manages the complete battery subsystem, allowing clients to concentrate on their core products and applications. With a production area of 1600 m² and a team of highly educated employees possessing extensive experience in electronics, software, and mechanical development, Alelion combines robust technical expertise with a commitment to efficient production processes. The company's evolution included a change of ownership in 2007 and a rebranding in 2016, highlighting its continuous growth and innovation in the energy storage sector.

NEC OncoImmunity

Grant in 2017
NEC OncoImmunity AS is a bioinformatics company based in Oslo, Norway, specializing in machine-learning software solutions aimed at enhancing cancer immunotherapy. Founded in 2014 and a subsidiary of NEC Corporation since 2019, the company focuses on identifying immunogenic neoantigens to improve personalized cancer treatments. Its platform supports patient selection for immunotherapy by determining optimal neoantigen targets for personalized vaccines and cell therapies within a clinically actionable timeframe. By providing tools that address critical knowledge gaps, NEC OncoImmunity enables healthcare institutions and research organizations to advance the development of effective neoantigen-based immunotherapies and biomarkers for cancer treatment.

Stalsmidjan Framtak

Grant in 2017
Stalsmidjan Framtak provides automated anode fork repair system for the aluminium rodding plant. The history of Stalsmidjan ehf. extends back to the year 1933. Ship repairs and conversions have always been the mainstream of the company's operations. The first steel boat to be built in Iceland was built by Stalsmidjan in 1955, a tugboat with 1000 hp main engine, for the Reykjavík Harbour Authorities. In 1962 Stalsmidjan also built the first Icelandic steel fishing boat. There is a long ship building tradition in the company, which has constructed and modified a total of 36 steel vessels, up to 68 meters in length. Stalsmidjan operates its own slipway in Reykjavík Harbour and a carpenter’s workshop, specialized in ship works and renovations of older woodwork. Stalsmidjan has wide experience in new buildings, improvements and maintenance work both for hydro electric power stations and steam turbine stations as well as in energy distribution systems. Framtak ehf. was founded in the year 1988. In the year 2000 Framtak bought the company Blossi hf, and established the daughter company Framtak-Blossi ehf. This company covers specialized diesel-tuning and automotive workshops, and is authorized as "Bosch Diesel Centre" in Iceland. It also operates a retail shop and services for the metal industry. Earlier, the main focus was on the marine sector and Framtak has covered some of the largest and most complicated machinery repair and installation projects, both for Icelandic and foreign owners, but later the land-based industry and the Icelandic power industry became more important factor in the company’s activities. This change in policy lead to contracts with prime companies in the power supply sector, like Orkuveita Reykjavikur, HS Orka, and Landsvirkjun, among others, and Framtak has undertaken and overseen some of the largest and most complicated geothermal power plant projects in Iceland in the recent years. In December 2006 Stalsmidjan bought all shares in Framtak and Framtak-Blossi ehf. and henceforth they worked closely together, with mutual office and workshop facilities in new housing in Gardabaer and a big workshop at Grundartangi. In 2013, Stalsmidjan and Framtak merged as Stalsmidjan – Framtak ehf. and is now one of the biggest company of its type in Iceland, offering a wide range of services and solutions in the machine, shipping and metal industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.